生长激素释放激素 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-29. Numbers and descriptions here follow the published literature rather than marketing material.
监管记录显示,特沙莫瑞林于 2010 年在美国首次获得批准,用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验,而非体重或瘦体重的普遍改善。后续出现了不同制剂版本,但其核心适应症保持一致。关于长期心血管结局和死亡率影响,现有证据仍不充分。
在临床研究之外,特沙莫瑞林常被讨论为生长激素分泌促进剂,但这一说法需要限定。它并不等同于生长激素本身,也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力,另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中,尚未形成统一结论。
特沙莫瑞林是一种合成肽,其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰,这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂,可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物,而非小分子化合物。
研究用与临床用材料的标准并不相同。质量控制通常覆盖纯度、残留溶剂、反离子含量、微生物限度与内毒素水平,各项均有对应检测方法。随货文件应包含批号、检测项目、方法与结果,使数据可以追溯。核验时应关注纯度是否按主峰面积计算、杂质是否已定性、方法是否经过验证,这些信息决定结果能否被外部重复。
纯度与身份确认依赖色谱与质谱的组合。反相高效液相色谱在 214 nm 紫外检测下分离主峰与相关杂质,给出纯度百分比与保留时间;电喷雾或基质辅助激光解吸电离质谱提供分子量,用于确认 N 端修饰是否完整。序列层面可通过肽图或氨基酸分析验证。含量测定常用紫外吸收法或氮元素分析,不同方法之间需要做交叉校验。
冻干粉末一般在 -20°C 或更低温度、干燥避光条件下保存,可维持较长时间的稳定。复溶后稳定性明显下降,溶液中的肽链易发生水解、氧化与聚集,通常需冷藏并在短期内用完。反复冻融会加速聚集与降解,建议分装后单次使用。缓冲体系的 pH 与离子强度同样影响聚集速率,需要按具体实验条件验证。
| Property | Value | Notes |
|---|---|---|
| 分子类型 | 合成肽 | 含 44 个氨基酸残基的 GHRH 类似物 |
| N 端修饰 | 反式-3-己烯酰基 | 用于抵抗二肽基肽酶 IV 降解 |
| 首次批准 | 2010 年,美国 | 用于 HIV 相关脂肪营养不良 |
| 作用靶点 | 生长激素释放激素受体 | 位于垂体前叶 |
| 主要研究终点 | 内脏脂肪变化 | 非总体重或瘦体重 |
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.
Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
ITUC stated their "total opposition" to all forms of corruption and "where corruption exists, workers are among its principal victims". ITUC stated that their decision to suspend Visentini "This in no way implies any presumption of guilt."
Europe has a basic choice: either it lapses back into the old power politics and balance of power diplomacy of past centuries or it moves ahead along the road leading to a new order of peace and freedom, whether this be based on multinational or supranational cooperation. Our choice is clear: we are going forward.According to historian Sverre Bagge, a balance of power logic may have prevented unification of the three Scandinavian kingdoms (Norway, Sweden and Denmark), as balancing coalitions formed to prevent one kingdom from conquering the other kingdoms.
This PFS benefit was consistent across subgroups with individual high-risk cytogenetic abnormalities, including patients with del(17p). PFS was also longer with IRd versus placebo- in patients with 1q21 amplification, and in the "expanded high-risk" group, defined as those with high-risk cytogenetic abnormalities and/or 1q21 amplification. IRd demonstrated substantial benefit compared with placebo in relapsed/refractory multiple myeloma patients with high-risk and standard-risk cytogenetics, and improves the poor PFS associated with high-risk cytogenetic abnormalities.
Chell is the player-character in both Portal games. She is a silent protagonist outside of small grunts during physical tasks. Very little truthful information is known about Chell; while GLaDOS makes many statements to Chell's background and history, GLaDOS herself admits she is unreliable. The only consistent fact that is used through the series is that Chell's parents gave her away. Whether they did it intentionally or not is unknown. Chell's appearance is modeled after Alésia Glidewell
Sitagliptin works to competitively inhibit the enzyme dipeptidyl peptidase 4 (DPP-4). This enzyme breaks down the incretins GLP-1 and GIP, gastrointestinal hormones released in response to a meal. By preventing breakdown of GLP-1 and GIP, they are able to increase the secretion of insulin and suppress the release of glucagon by the alpha cells of the pancreas. This drives blood glucose levels towards normal. As the blood glucose level approaches normal, the amounts of insulin released and glucagon suppressed diminishes, thus tending to prevent an "overshoot" and subsequent low blood sugar (hypoglycemia), which is seen with some other oral hypoglycemic agents. Sitagliptin has been shown to lower HbA1c level by about 0.7% points versus placebo. It is slightly less effective than metformin when used as a monotherapy. It does not cause weight gain and has less hypoglycemia compared to sulfonylureas. Sitagliptin is recommended as a second-line drug (in combination with other drugs) after the combination of diet/exercise and metformin fails.
Sources: en.wikipedia.org
This reaction is part of biochemical pathway called the hydantoinase process which converts 5-substituted hydantoins into optically pure D- or L-amino acids. This enzyme is a hydrolase which act on carbon-nitrogen bonds other than peptide bonds, specifically in linear amides. The systematic name of this enzyme class is N-carbamoyl-L-amino acid amidohydrolase.
The four substrates of this enzyme are phthalic acid, nicotinamide adenine dinucleotide (NADH), oxygen, and a proton. Its products are cis-4,5-dihydroxycyclohexa-2,6-diene-1,2-dicarboxylic acid and NAD+. This enzyme belongs to the family of oxidoreductases, specifically those acting on paired donors, with molecular oxygen as oxidant and incorporation or reduction of oxygen. The systematic name of its class is phthalate,NADH:oxygen oxidoreductase (4,5-hydroxylating). Other names in common use include PDO, and phthalate dioxygenase. The enzyme participates in 2,4-dichlorobenzoate degradation. It is an Iron-sulfur protein which uses flavin mononucleotide as a cofactor.
National Security Agency monitored a telephone conversation between Noriega and Luis Córdoba, the military commander in Chiriquí province where Spadafora was arrested. During the conversation Córdoba told Noriega, "We have the rabid dog." Noriega responded, "And what does one do with a dog that has rabies?" Spadafora's murder badly damaged Noriega's image, both within and outside Panama, and created a crisis for the Panamanian regime. Barletta, who was in New York City when Spadafora was murdered in September 1985, announced his intention to appoint an independent commission to investigate the murder. Upon his return to Panama, however, he was forced to resign by the PDF and was replaced by Vice President Eric Arturo Delvalle. Barletta was highly regarded in the Reagan administration, and his removal brought a downturn in the relations between the U.S. and Noriega. After Spadafora's murder the U.S. began to view Noriega as a liability rather than an asset, despite his ongoing support for U.S. interventions elsewhere. The U.S. response included reducing economic assistance and pressuring Panama to reform its banking secrecy laws, crack down on narcotics trafficking, investigate the murder of Spadafora, and reduce the PDF's role in the government. The response to Spadafora's murder created divisions within the PRD, and further damaged the credibility of the government-controlled news media.
King Mendre, or the King of Persia (Polosi) or Anandavarma the kings of Tukhara (覩货罗, Tokharistan) had images painted in these caves for all the followers of the Buddha, by the artist and painter Mitradatta, also by Naravahanadatta, who came from a place of worship of the Niganthas, finally by Priyaratna who came from Syria (Rumakama, "Roman Empire") also with their apprentices. King Mendre and the King of Tukhara received the relics of Amitabha and went into the land of blessedness (Sukhavati). The son of the King of Tukhara called Dahuangfa (大黄发王) came to the city of Mir-li, preached the Kalachakra to all the Jaina-Niganthas and restored all the caves for the worship of Buddha. According to a recent translation by Sam van Schaik, the text should be:
Sources: en.wikipedia.org
== Production and occurrence == Pentane is produced by fractional distillation of petroleum and purified by rectification (successive distillations). It occurs in alcoholic beverages and in hop oil. It is a component of exhaled breath for some individuals. A degradation product of unsaturated fatty acids, its presence is associated with some diseases and cancers. Pentane is a relatively minor component of automobile gasoline, with its share varying within 1–6% in 1990s Sweden, 2–13% in 1990s US and 1–3% in the US in 2011. At 62, its octane number (both RON and MON) is quite low.
Barnsley F.C. on BBC Sport: Club news – Recent results and fixtures Barnsley at ScoreShelf (archived) Barnsley FC at the Barnsley Chronicle Barnsley FC Supporters Trust (archived) BBC South Yorkshire's Barnsley FC Page Barnsley Statistics at Football365 (archived) Independent Barnsley FC News – barnsleyfc.com (archived) Barnsley FC News at NewsNow
=== Issues of dosage quantification and standardization === As Knopp and her associates note (JK.1), a manufacturer's standard sample has its universally agreed-upon potency (i.e., its specific biological activity) precisely expressed, by convention, in international units (IU), with one international unit of insulin (1 IU) defined as the "biological equivalent" of 34.7 μg pure crystalline insulin. Yet, as they also note, there is no universally agreed-upon "conversion factor" to express the mass of that same sample in International System Units (SI).
Men with gynecomastia may appear anxious or stressed due to concerns about its appearance and the possibility of having breast cancer. Particular studies suggest that gynecomastia can lead to various psychological and social challenges, such as depression, anxiety and disordered eating.
Protection: One of the main functions of the oral mucosa is to physically protect the underlying tissues from the mechanical forces, microbes and toxins in the mouth. Keratinised masticatory mucosa is tightly bound to the hard palate and gingivae. It accounts for 25% of all oral mucosa. It supports underlying tissues by resisting the loading forces exerted during mastication. Lining mucosa in the cheeks, lips and floor of mouth is mobile to create space when chewing and talking. During mastication, it allows food to move freely around the mouth and physically protects the underlying tissues from trauma. It accounts for 60% of oral mucosa. Secretion: Saliva is the primary secretion of the oral mucosa. It has many functions including lubrication, pH buffering and immunity. The lubricating and antimicrobial functions of saliva are maintained mainly by resting; saliva results in a flushing effect and the clearance of oral debris and noxious agents. Saliva contains numerous antimicrobial proteins that help protect the oral ecosystem from infectious agent. The components like lysozyme, lactoferrin, salivary peroxidase, myeloperoxidase, and thiocyanate concentrations act as a defense mechanism in the saliva. Saliva is secreted from 3 pairs of major salivary glands (parotid, submandibular, sublingual) alongside many minor salivary glands. It also aids the initial chemical digestion of food as it contains the enzyme amylase, responsible for breaking carbohydrates into sugars.
Sources: en.wikipedia.org
特沙莫瑞林是国际非专利名称,指一种经过 N 端修饰的生长激素释放激素类似物。它被归类为合成肽,序列与 GHRH(1-44) 密切相关。该名称不指代任何特定品牌或剂型。
监管批准集中于 HIV 感染相关的脂肪营养不良,目的是减少内脏脂肪。它未被批准用于普通肥胖或一般体重管理。不同国家的批准状态和标签范围可能不同。
长期心血管获益、死亡率影响以及停药后的持续性仍缺乏确证。部分研究提示 IGF-1 和血糖参数可能变化,但个体差异较大。这些开放问题需要更长期、更大规模的试验来回答。
多肽在反相柱上按疏水性差异分离,能有效区分主峰、缺失序列片段与氧化产物。配合紫外检测可获得可量化的纯度百分比,是肽类分析的常规手段。